Novel brominated vinylic fatty acids effectively inhibit the leishmania topoisomerase IB enzyme mediated by halogen bond formation (2019)
- Authors:
- USP affiliated authors: ANDRICOPULO, ADRIANO DEFINI - IFSC ; FERREIRA, LEONARDO LUIZ GOMES - IFSC
- Unidade: IFSC
- Subjects: PLANEJAMENTO DE FÁRMACOS; LEISHMANIA
- Language: Inglês
- Imprenta:
- Publisher: American Society of Pharmacognosy - ASP
- Publisher place: Northbrook
- Date published: 2019
- Source:
- Título: Abstracts
- Conference titles: Annual Meeting of the American Society of Pharmacognosy - ASP
-
ABNT
CARBALLEIRA, Néstor M. et al. Novel brominated vinylic fatty acids effectively inhibit the leishmania topoisomerase IB enzyme mediated by halogen bond formation. 2019, Anais.. Northbrook: American Society of Pharmacognosy - ASP, 2019. Disponível em: http://aspmeetings.pharmacognosy.us/wp-content/uploads/2019/07/ASP2019-Electronic-Program-and-Abstract-Book-Final.pdf. Acesso em: 13 fev. 2026. -
APA
Carballeira, N. M., Alequín, D., Lotti, L. M., Matos, V. J., Ferreira, L. L. G., Andricopulo, A. D., et al. (2019). Novel brominated vinylic fatty acids effectively inhibit the leishmania topoisomerase IB enzyme mediated by halogen bond formation. In Abstracts. Northbrook: American Society of Pharmacognosy - ASP. Recuperado de http://aspmeetings.pharmacognosy.us/wp-content/uploads/2019/07/ASP2019-Electronic-Program-and-Abstract-Book-Final.pdf -
NLM
Carballeira NM, Alequín D, Lotti LM, Matos VJ, Ferreira LLG, Andricopulo AD, Reguera RM, Pérez-Pertejo Y, Balaña-Fouce R. Novel brominated vinylic fatty acids effectively inhibit the leishmania topoisomerase IB enzyme mediated by halogen bond formation [Internet]. Abstracts. 2019 ;[citado 2026 fev. 13 ] Available from: http://aspmeetings.pharmacognosy.us/wp-content/uploads/2019/07/ASP2019-Electronic-Program-and-Abstract-Book-Final.pdf -
Vancouver
Carballeira NM, Alequín D, Lotti LM, Matos VJ, Ferreira LLG, Andricopulo AD, Reguera RM, Pérez-Pertejo Y, Balaña-Fouce R. Novel brominated vinylic fatty acids effectively inhibit the leishmania topoisomerase IB enzyme mediated by halogen bond formation [Internet]. Abstracts. 2019 ;[citado 2026 fev. 13 ] Available from: http://aspmeetings.pharmacognosy.us/wp-content/uploads/2019/07/ASP2019-Electronic-Program-and-Abstract-Book-Final.pdf - 3D QSAR studies for a series of Trypanosoma cruzi dehydrogenase inhibitors
- COVID-19: small-molecule clinical trials landscape [Editorial]
- Pyrazolines as potential anti-Alzheimer's agents: DFT, molecular docking, enzyme inhibition and pharmacokinetic studies
- Cancer estimates in Brazil reveal progress for the most lethal malignancies [Editorial]
- In vitro leishmanicidal activity of novel N-arylspermidine derivatives
- Chemoinformatics approaches to structure- and ligand-based drug design
- Empowering neglected tropical disease drug discovery with translational medicinal chemistry. [Editorial]
- World chagas disease day and the new road map for neglected tropical diseases. [Editorial]
- Evaluation of pyrazolines as anti-alzheimer's agents: DFT, molecular docking, enzyme inhibition and pharmacokinetic studies
- Experimental and computational investigations on a series of drug candidates for Chagas disease
How to cite
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
